Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shaun G Goodman

Showing results (71-80 of 515) with videos related to

Pageof 52
Sort By:
European Heart Journal|June 1, 2011
Implications of variability in definition and reporting of major bleeding in randomized trials of oral P2Y12 inhibitors for acute coronary syndromesDaniel J Quinlan, John W Eikelboom, Shaun G Goodman, et al.
Archives of Internal Medicine|May 30, 2007
Management patterns in relation to risk stratification among patients with non-ST elevation acute coronary syndromesAndrew T Yan, Raymond T Yan, Mary Tan, et al.
Journal of the American Heart Association|July 25, 2022
Trends in Uptake and Adherence to Oral Anticoagulation for Patients With Incident Atrial Fibrillation at High Stroke Risk Across Health Care SettingsHaran Yogasundaram, Douglas C Dover, Nathaniel M Hawkins, et al.
Archives of Internal Medicine|February 25, 2009
Understanding physicians' risk stratification of acute coronary syndromes: insights from the Canadian ACS 2 RegistryAndrew T Yan, Raymond T Yan, Thao Huynh, et al.
American Heart Journal|October 18, 2008
Clinical implications of a next-day follow-up electrocardiogram in patients with non-ST elevation acute coronary syndromesSalem Alkaabi, Fahad Baslaib, Amparo Casanova, et al.
The Canadian Journal of Cardiology|June 26, 2016
Secondary Prevention Beyond Hospital Discharge for Acute Coronary Syndrome: Evidence-Based RecommendationsDavid H Fitchett, Shaun G Goodman, Lawrence A Leiter, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|July 8, 2024
Rivaroxaban Versus Apixaban: A Comparison Without a Simple SolutionMarc Cohen, Alex C Spyropoulos, Shaun G Goodman, et al.
Archives of Internal Medicine|February 13, 2008
Use of cardiac catheterization for non-ST-segment elevation acute coronary syndromes according to initial risk: reasons why physicians choose not to refer their patientsCindy H Lee, Mary Tan, Andrew T Yan, et al.
The Journal of Invasive Cardiology|September 16, 2016
Short Duration vs Standard Duration of Dual-Antiplatelet Therapy After Percutaneous Coronary Intervention With Second-Generation Drug-Eluting Stents - A Systematic Review, Meta-Analysis, and Meta-Regression Analysis of Randomized Controlled TrialsAnthony W A Wassef, Hadi Khafaji, Ishba Syed, et al.
The American Journal of Cardiology|October 11, 2005
Short- and long-term outcomes of patients with electrocardiographic left ventricular hypertrophy after fibrinolysis for acute myocardial infarctionAlina Georgescu, Yuling Fu, Cynthia Yau, et al.
Pageof 52

Showing results (71-80 of 515) with videos related to

Sort By:
Pageof 52
European Heart Journal|June 1, 2011
Implications of variability in definition and reporting of major bleeding in randomized trials of oral P2Y12 inhibitors for acute coronary syndromesDaniel J Quinlan, John W Eikelboom, Shaun G Goodman, et al.
Archives of Internal Medicine|May 30, 2007
Management patterns in relation to risk stratification among patients with non-ST elevation acute coronary syndromesAndrew T Yan, Raymond T Yan, Mary Tan, et al.
Journal of the American Heart Association|July 25, 2022
Trends in Uptake and Adherence to Oral Anticoagulation for Patients With Incident Atrial Fibrillation at High Stroke Risk Across Health Care SettingsHaran Yogasundaram, Douglas C Dover, Nathaniel M Hawkins, et al.
Archives of Internal Medicine|February 25, 2009
Understanding physicians' risk stratification of acute coronary syndromes: insights from the Canadian ACS 2 RegistryAndrew T Yan, Raymond T Yan, Thao Huynh, et al.
American Heart Journal|October 18, 2008
Clinical implications of a next-day follow-up electrocardiogram in patients with non-ST elevation acute coronary syndromesSalem Alkaabi, Fahad Baslaib, Amparo Casanova, et al.
The Canadian Journal of Cardiology|June 26, 2016
Secondary Prevention Beyond Hospital Discharge for Acute Coronary Syndrome: Evidence-Based RecommendationsDavid H Fitchett, Shaun G Goodman, Lawrence A Leiter, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|July 8, 2024
Rivaroxaban Versus Apixaban: A Comparison Without a Simple SolutionMarc Cohen, Alex C Spyropoulos, Shaun G Goodman, et al.
Archives of Internal Medicine|February 13, 2008
Use of cardiac catheterization for non-ST-segment elevation acute coronary syndromes according to initial risk: reasons why physicians choose not to refer their patientsCindy H Lee, Mary Tan, Andrew T Yan, et al.
The Journal of Invasive Cardiology|September 16, 2016
Short Duration vs Standard Duration of Dual-Antiplatelet Therapy After Percutaneous Coronary Intervention With Second-Generation Drug-Eluting Stents - A Systematic Review, Meta-Analysis, and Meta-Regression Analysis of Randomized Controlled TrialsAnthony W A Wassef, Hadi Khafaji, Ishba Syed, et al.
The American Journal of Cardiology|October 11, 2005
Short- and long-term outcomes of patients with electrocardiographic left ventricular hypertrophy after fibrinolysis for acute myocardial infarctionAlina Georgescu, Yuling Fu, Cynthia Yau, et al.
Pageof 52